JSAM
HAE icon

J. Safra Asset Management’s Haemonetics HAE Stock Holding History

J. Safra Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.4K Hold
72
– – ﹤0.01% 488
2026
Q1 		$4.06K Buy
72
+34
+89% +$2.21K ﹤0.01% 508
2025
Q4 		$3.05K Hold
38
– – ﹤0.01% 497
2025
Q3 		$1.85K Sell
38
-185
-83% -$11.5K ﹤0.01% 422
2025
Q2 		$16.6K Sell
223
-94
-30% -$6.22K ﹤0.01% 259
2025
Q1 		$20.1K Buy
317
+74
+30% +$5.03K ﹤0.01% 234
2024
Q4 		$18.6K Buy
243
+69
+40% +$5.54K ﹤0.01% 253
2024
Q3 		$13.9K Buy
+174
New +$14.1K ﹤0.01% 219

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

J. Safra Asset Management's HAE Position: Q2 2026 in Review

J. Safra Asset Management held its Haemonetics (HAE) position steady in Q2 2026 at 72 shares worth $5.4K. The position accounts for ﹤0.01% of the portfolio, ranked #488.

J. Safra Asset Management first reported a position in HAE in Q3 2024 and has held it in 8 quarters since. The position peaked at $20.1K in Q1 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • J. Safra Asset Management held 72 shares of Haemonetics worth $5.4K as of Q2 2026.
  • J. Safra Asset Management left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #488 holding.
  • J. Safra Asset Management first reported a position in Haemonetics in Q3 2024 and has held it in 8 quarters since.
  • J. Safra Asset Management's Haemonetics position peaked at $20.1K in Q1 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.